DMARDS

Immunogenicity and benefits of third shot

A red-letter day for rituximab

No significant link between cancer and bDMARDs

Cutting RA meds worth a go: study

TGA approves more covid drugs

Some DMARDs may lower CVD risk in RA patients

Repurposing rheuma drugs to treat COVID

Rituximab and JAK inhibitors linked to higher covid-19 mortality
